Health News Archive - February 23, 2009
SEROQUEL XR is Now Approved to Treat the Depressive, Manic, and Mixed Episodes of Bipolar Disorder WILMINGTON, Del., Feb.
CHADDS FORD, Pa., Feb. 23 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced the successful completion of the tender offer by its wholly owned subsidiary, BTB Purchaser Inc., for all of the outstanding shares of common stock of Indevus Pharmaceuticals, Inc.
A team of scientists has created miniscule flakes of silicon that glow brightly, last long enough to slowly release cancer drugs, then break down into harmless by-products.
MALVERN, Pa. and SHANGHAI, Feb. 23 /PRNewswire/ -- Frontage Laboratories Inc.
NEW YORK, Feb. 23 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc.
SAN ANTONIO, Feb. 23 /PRNewswire/ --HealthyPlace.com, which provides the most extensive depression and anxiety information on the internet, unveils several important new features for those who suffer from mood disorder-related illnesses.
LIVINGSTON, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it will be exhibiting at the upcoming Chicago Dental Society's 144th Midwinter Meeting in Chicago.
MCLEAN, Va., Feb. 23 /PRNewswire-FirstCall/ -- Sunrise Senior Living, Inc. (NYSE: SRZ) today announced that it will host a conference call and Webcast on Monday, March 2, 2009, at 9 a.m. ET to discuss the financial results for the fourth-quarter and full-year 2008.
SACRAMENTO, Calif., Feb.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.